Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases
Clinical trial NCT06163820 · RECRUITING
Trial details
- NCT number
- NCT06163820
- Sponsor
- Melanoma and Skin Cancer Trials Limited
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-31
- Primary completion
- 2026-01-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.